Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Mauna Kea Technologies's operating assets for the quarter that ended in Dec. 2025 was €8.44 Mil. Mauna Kea Technologies's operating liabilities for the quarter that ended in Dec. 2025 was €6.15 Mil. Mauna Kea Technologies's Total Assets for the quarter that ended in Jun. 2025 was €12.66 Mil. Therefore, Mauna Kea Technologies's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2025 was 0.18.
Mauna Kea Technologies Scaled Net Operating Assets Related Terms
Mauna Kea Technologies Scaled Net Operating Assets Historical Data
* Premium members only.
The historical data trend for Mauna Kea Technologies's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mauna Kea Technologies Scaled Net Operating Assets Chart
XPAR:ALMKT vs ABT, SYK, MDT: Scaled Net Operating Assets Comparison
For the Medical Devices subindustry, Mauna Kea Technologies's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mauna Kea Technologies Scaled Net Operating Assets vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Mauna Kea Technologies's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Mauna Kea Technologies's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of 0.18 mean?
Mauna Kea Technologies (XPAR:ALMKT) has a Scaled Net Operating Assets of 0.18 as of Dec. 2025. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Mauna Kea Technologies and its competitors.
Is Mauna Kea Technologies' Scaled Net Operating Assets too high?
Mauna Kea Technologies' current Scaled Net Operating Assets is 0.18. Overall, Mauna Kea Technologies has a GF Score™ of 39/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mauna Kea Technologies' Scaled Net Operating Assets compare to ABT and SYK?
Mauna Kea Technologies' Scaled Net Operating Assets of 0.18 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Medical Devices & Instruments company?
A good Scaled Net Operating Assets depends on the Medical Devices & Instruments industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Mauna Kea Technologies and its competitors. Mauna Kea Technologies's current Scaled Net Operating Assets is 0.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mauna Kea Technologies stock overvalued right now?
Based on GuruFocus' analysis, Mauna Kea Technologies (XPAR:ALMKT) is currently considered Fairly Valued. The stock's GF Value™ is €0.14, compared to a current price of €0.16 — trading 10.7% above its estimated fair value. The current Scaled Net Operating Assets is 0.18. Mauna Kea Technologies' overall GF Score™ is 39/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Mauna Kea Technologies (XPAR:ALMKT), the current Scaled Net Operating Assets is 0.18 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mauna Kea Technologies (XPAR:ALMKT) Overvalued in 2026?
Based on GuruFocus' analysis, Mauna Kea Technologies stock appears to be overvalued.
The current stock price of €0.16 is trading 10.7% above its estimated GF Value™ of €0.14.
GuruFocus considers Mauna Kea Technologies to be Fairly Valued.
Key valuation signals for XPAR:ALMKT:
Scaled Net Operating Assets: 0.18
GF Value™: €0.14 vs. price of €0.16 (10.7% above fair value)
No single metric tells the full story. See the XPAR:ALMKT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mauna Kea Technologies SA is a medical device company that develops, manufactures and markets an imaging platform for visualizing tissue at the cellular level, in real time, during standard procedures, with the mission of eliminating uncertainties in diagnosis and treatment through direct visualization of tissue in vivo at the microscopic level. The company's flagship product, Cellvizio, is the smallest microscope, designed for direct use during minimally invasive procedures. It operates in a single business segment: endomicroscopy. Its geographical presence includes EMEA (Europe, Middle East, Africa), USA and Canada, and Asia, of which the majority of the revenue is generated from USA and Canada.
39GF Score
Get the complete analysis for XPAR:ALMKT
Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ALMKT has been successfully added to your 
